Start Submission Become a Reviewer

Reading: Correction: Vital Signs During the COVID-19 Outbreak: A Retrospective Analysis of 19,960 Par...

Download

A- A+
Alt. Display

Correction

Correction: Vital Signs During the COVID-19 Outbreak: A Retrospective Analysis of 19,960 Participants in Wuhan and Four Nearby Capital Cities in China

Authors:

Jing-Wei Li,

Department of Cardiology, People’s Liberation Army General Hospital, Beijing, CN; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, NSW, Sydney, AU; Department of Cardiology, Xinqiao Hospital, Army Military Medical University, Chongqing, CN
X close

Yu-Tao Guo,

Department of Cardiology, People’s Liberation Army General Hospital, Beijing, CN
X close

Gian Luca Di Tanna,

The George Institute for Global Health, Faculty of Medicine, University of New South Wales, NSW, Sydney, AU
X close

Bruce Neal,

The George Institute for Global Health, Faculty of Medicine, University of New South Wales, NSW, Sydney, AU; Imperial College London, London, GB
X close

Yun-Dai Chen ,

Department of Cardiology, People’s Liberation Army General Hospital, Beijing; Medical School, People’s Liberation Army General Hospital, Beijing, CN
X close

Aletta E. Schutte

The George Institute for Global Health, Faculty of Medicine, University of New South Wales, NSW, Sydney, AU
X close

Abstract

This article details a correction to: Li J-W, Guo Y-T, Di Tanna GL, Neal B, Chen Y-D, Schutte AE. Vital Signs During the COVID-19 Outbreak: A Retrospective Analysis of 19,960 Participants in Wuhan and Four Nearby Capital Cities in China. Global Heart. 2021;16(1):47. DOI: http://doi.org/10.5334/gh.913.

Keywords: COVID-19, Cardiology
How to Cite: Li J-W, Guo Y-T, Di Tanna GL, Neal B, Chen Y-D, Schutte AE. Correction: Vital Signs During the COVID-19 Outbreak: A Retrospective Analysis of 19,960 Participants in Wuhan and Four Nearby Capital Cities in China. Global Heart. 2022;17(1):88. DOI: http://doi.org/10.5334/gh.1172
20
Views
6
Downloads
  Published on 20 Dec 2022
 Accepted on 07 Nov 2022            Submitted on 07 Nov 2022

Correction

The original article1 was published without complete funding details. It listed one funder, the National Natural Science Foundation of China (H2501), National Key Research and Development Project of China (2018YFC2001200).

There was another funder missing from the original article, the Chinese Military Health Care (20BJZ26).

The originally listed funder covered expenses for enrolment and follow-up of patients, and the purchase and maintenance of necessary equipment. The second funder covered the costs of publication.

Notes

Competing Interests

J.L. held an International Postdoctoral Exchange Fellowship Program China (20170103) during the course of this work.

G. Tao has no disclosures.

A.E. Schutte received speaker honoraria from Omron Healthcare, Takeda Pharmaceuticals, Novartis, Servier, and serves on research advisory board for Abbott. She is President of the International Society of Hypertension, 2018–2020.

G.L. Di Tanna has no disclosures.

B. Neal is supported by an Australian National Health and Medical Research Council Principal Research Fellowship; holds a research grant for this study from Janssen; and has held research grants for other large-scale cardiovascular outcome trials from Roche, Servier, and Merck Schering Plough; and his institution has received consultancy, honoraria, or travel support for contributions he has made to advisory boards and/or the continuing medical education programs of Abbott, Janssen, Novartis, Pfizer, Roche, and Servier.

Y. Chen has no disclosures.

comments powered by Disqus